Related Experiment Video
Updated: Jun 25, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Effects of Garlic on Breast Tumor Cells with a Triple Negative Phenotype: Peculiar Subtype-Dependent Down-Modulation
Federica Brugnoli1, Marcello Dell'Aira1, Paola Tedeschi2
1Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
Abstract:
Breast cancer includes tumor subgroups with morphological, molecular, and clinical differences. Intrinsic heterogeneity especially characterizes breast tumors with a triple negative phenotype, often leading to the failure of even the most advanced therapeutic strategies. To improve breast cancer treatment, the use of natural agents to integrate conventional therapies is the subject of ever-increasing attention. In this context, garlic (Allium sativum) shows anti-cancerous potential, interfering with the proliferation, motility, and malignant progression of both non-invasive and invasive breast tumor cells. As heterogeneity could be at the basis of variable effects, the main objective of our study was to evaluate the anti-tumoral activity of a garlic extract in breast cancer cells with a triple negative phenotype. Established triple negative breast cancer (TNBC) cell lines from patient-derived xenografts (PDXs) were used, revealing subtype-dependent effects on morphology, cell cycle, and invasive potential, correlated with the peculiar down-modulation of Akt signaling, a crucial regulator in solid tumors. Our results first demonstrate that the effects of garlic on TNBC breast cancer are not unique and suggest that only more precise knowledge of the mechanisms activated by this natural compound in each tumor will allow for the inclusion of garlic in personalized therapeutic approaches to breast cancer.
Insights
Garlic extract shows anti-tumoral effects on triple-negative breast cancer (TNBC) cells, but its impact varies by subtype. Further research into garlic
Area of Science:
- Oncology
- Pharmacology
- Natural Products Chemistry
Background:
- Breast cancer exhibits significant heterogeneity, particularly triple-negative breast cancer (TNBC), complicating treatment outcomes.
- Natural agents, like garlic (Allium sativum), are increasingly explored for their potential to complement conventional cancer therapies.
- Garlic demonstrates anti-proliferative and anti-metastatic properties against various cancer cells.
Purpose of the Study:
- To investigate the anti-tumoral activity of a garlic extract specifically in triple-negative breast cancer (TNBC) cell lines.
- To explore how tumor heterogeneity influences the efficacy of garlic extract in TNBC.
- To elucidate the molecular mechanisms underlying garlic's effects on TNBC.
Main Methods:
- Utilized established triple-negative breast cancer (TNBC) cell lines derived from patient-derived xenografts (PDXs).
- Evaluated the effects of garlic extract on cell morphology, cell cycle progression, and invasive potential.
- Assessed the modulation of Akt signaling pathways in response to garlic treatment.
Main Results:
- Garlic extract exhibited subtype-dependent effects on TNBC cell morphology, cell cycle, and invasiveness.
- Observed a significant down-modulation of Akt signaling, a key regulator in tumor progression.
- Demonstrated that the anti-tumoral effects of garlic are not uniform across all TNBC subtypes.
Conclusions:
- Garlic extract possesses anti-tumoral activity against triple-negative breast cancer, but its efficacy is influenced by tumor heterogeneity.
- The observed effects are partly mediated through the modulation of the Akt signaling pathway.
- Personalized therapeutic strategies incorporating garlic require a deeper understanding of its specific mechanisms in distinct TNBC subtypes.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
Targeted Cancer Therapies
There are several types of targeted therapies against...

